{"schema_version":"secwatch.filing_event.v1","accession":"0001104659-21-145529","form_type":"8-K","ticker":"PTPI","cik":"0001815903","company_name":"Petros Pharmaceuticals, Inc.","filed_at":"2021-12-01T23:59:59+00:00","discovered_at":"2026-05-14T18:04:14.283761+00:00","generated_at":"2026-06-28T04:33:54.588583+00:00","sec_items":["1.01","3.02","8.01","9.01"],"event_type":"other_material","sentiment":"neutral","materiality_score":0.7,"calibrated_materiality_score":0.7,"confidence":"high","headline":"Petros Pharmaceuticals raises $10M in registered direct offering and private placement","bullets":["Gross proceeds of $10M from sale of 3,333,333 shares at $3.00/share; net proceeds ~$9.3M.","Issues warrants to purchase 2,500,000 shares at $3.50/share, exercisable for 5 years.","Largest shareholder among existing investors; Katalyst Securities acted as financial advisor.","Proceeds to be used for men's health platform expansion and general corporate purposes.","Closing expected on or about December 2, 2021, subject to customary conditions."],"urls":{"canonical":"https://secwatch.observer/filing/0001104659-21-145529","json":"https://secwatch.observer/filing/0001104659-21-145529.json","markdown":"https://secwatch.observer/filing/0001104659-21-145529.md","text":"https://secwatch.observer/filing/0001104659-21-145529.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1815903/000110465921145529/0001104659-21-145529-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1815903/000110465921145529/tm2134293d1_8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-28T04:33:54.588583+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}